These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14626429)

  • 21. PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase.
    Luciani JJ; Depetris D; Usson Y; Metzler-Guillemain C; Mignon-Ravix C; Mitchell MJ; Megarbane A; Sarda P; Sirma H; Moncla A; Feunteun J; Mattei MG
    J Cell Sci; 2006 Jun; 119(Pt 12):2518-31. PubMed ID: 16735446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
    Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
    mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.
    Pampin M; Simonin Y; Blondel B; Percherancier Y; Chelbi-Alix MK
    J Virol; 2006 Sep; 80(17):8582-92. PubMed ID: 16912307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies.
    Fuchsová B; Novák P; Kafková J; Hozák P
    J Cell Biol; 2002 Aug; 158(3):463-73. PubMed ID: 12163469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteasome-dependent dispersal of PML nuclear bodies in response to alkylating DNA damage.
    Conlan LA; McNees CJ; Heierhorst J
    Oncogene; 2004 Jan; 23(1):307-10. PubMed ID: 14712236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional organization of promyelocytic leukemia nuclear bodies.
    Lang M; Jegou T; Chung I; Richter K; Münch S; Udvarhelyi A; Cremer C; Hemmerich P; Engelhardt J; Hell SW; Rippe K
    J Cell Sci; 2010 Feb; 123(Pt 3):392-400. PubMed ID: 20130140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.
    Bell P; Lieberman PM; Maul GG
    J Virol; 2000 Dec; 74(24):11800-10. PubMed ID: 11090180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
    Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
    J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Implication of PML nuclear bodies in intrinsic and innate immunity].
    Maroui MA; El Asmi F; Dutrieux J; Chelbi-Alix MK; Nisole S
    Med Sci (Paris); 2014; 30(8-9):765-71. PubMed ID: 25174753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KAP1 depletion increases PML nuclear body number in concert with ultrastructural changes in chromatin.
    Kepkay R; Attwood KM; Ziv Y; Shiloh Y; Dellaire G
    Cell Cycle; 2011 Jan; 10(2):308-22. PubMed ID: 21228624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research advances on function of promyelocytic leukemia (PML) protein].
    He PC; Zhang M; Wang F
    Ai Zheng; 2003 Dec; 22(12):1359-62. PubMed ID: 14693070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
    Patra U; Müller S
    Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body language: the function of PML nuclear bodies in apoptosis regulation.
    Hofmann TG; Will H
    Cell Death Differ; 2003 Dec; 10(12):1290-9. PubMed ID: 12934066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus.
    Nakahara T; Lambert PF
    Virology; 2007 Sep; 366(2):316-29. PubMed ID: 17543368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
    Adamson AL; Kenney S
    J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
    Engelhardt OG; Ullrich E; Kochs G; Haller O
    Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PML bodies: a meeting place for genomic loci?
    Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
    J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection.
    Guion LG; Sapp M
    Front Cell Infect Microbiol; 2020; 10():35. PubMed ID: 32154186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death?
    Sanchez-Pulido L; Valencia A; Rojas AM
    Trends Biochem Sci; 2007 Sep; 32(9):400-6. PubMed ID: 17693089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.